Nothing Special   »   [go: up one dir, main page]

DK1025237T3 - Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder - Google Patents

Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder

Info

Publication number
DK1025237T3
DK1025237T3 DK98966890T DK98966890T DK1025237T3 DK 1025237 T3 DK1025237 T3 DK 1025237T3 DK 98966890 T DK98966890 T DK 98966890T DK 98966890 T DK98966890 T DK 98966890T DK 1025237 T3 DK1025237 T3 DK 1025237T3
Authority
DK
Denmark
Prior art keywords
hcds1
protein
methods
preparations
checkpoint kinase
Prior art date
Application number
DK98966890T
Other languages
Danish (da)
English (en)
Inventor
Walter H M L Luyten
Andrew E Parker
Clare Mcgowan
Alessandra Blasina
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of DK1025237T3 publication Critical patent/DK1025237T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98966890T 1997-10-22 1998-10-21 Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder DK1025237T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722320.0A GB9722320D0 (en) 1997-10-22 1997-10-22 Human cell cycle checkpoint proteins

Publications (1)

Publication Number Publication Date
DK1025237T3 true DK1025237T3 (da) 2005-11-28

Family

ID=10820925

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98966890T DK1025237T3 (da) 1997-10-22 1998-10-21 Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
DK98955533T DK1025236T3 (da) 1997-10-22 1998-10-21 Human checkpoint kinase, HCDS1, præparater og fremgangsmåde

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98955533T DK1025236T3 (da) 1997-10-22 1998-10-21 Human checkpoint kinase, HCDS1, præparater og fremgangsmåde

Country Status (13)

Country Link
US (4) US6531312B1 (fr)
EP (2) EP1025237B1 (fr)
JP (2) JP4418103B2 (fr)
AT (2) ATE300619T1 (fr)
AU (2) AU752617B2 (fr)
CA (2) CA2306492C (fr)
DE (2) DE69831500T2 (fr)
DK (2) DK1025237T3 (fr)
ES (2) ES2245050T3 (fr)
GB (1) GB9722320D0 (fr)
IL (2) IL135687A (fr)
NZ (2) NZ503983A (fr)
WO (2) WO1999020747A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins
AU4289599A (en) * 1998-06-23 2000-01-10 Chugai Seiyaku Kabushiki Kaisha Cell cycle regulatory factor
GB9827430D0 (en) * 1998-12-11 1999-02-03 Ludwig Inst Cancer Res Differential expression in primary breast cancer
WO2001061016A2 (fr) * 2000-02-18 2001-08-23 Lexicon Genetics Incorporated Nouvelles kinases humaines et nouveaux polynucleotides codant pour ces kinases
EP1265992A2 (fr) * 2000-03-08 2002-12-18 Zealand Pharma A/S SUBSTANCES ET PROCEDES LIES A LA DEGRADATION DE Cdc25A EN REPONSE A UN DOMMAGE DE L'ADN
AU2001255573A1 (en) * 2000-04-20 2001-11-07 Incyte Genomics, Inc. Human kinases
US6323016B1 (en) 2000-06-09 2001-11-27 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
FR2812945B1 (fr) * 2000-08-10 2002-10-04 Aventis Pharma Sa Utilisation de la proteine grf1 et cellules exprimant la proteine grf1 pour le criblage de molecules
US6372468B1 (en) 2000-09-14 2002-04-16 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002048328A2 (fr) * 2000-12-14 2002-06-20 Pe Corporation (Ny) Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees
WO2002051858A2 (fr) * 2000-12-22 2002-07-04 Isis Pharmaceuticals, Inc. Modulation antisens de l'expression de chk2
US6451538B1 (en) 2000-12-22 2002-09-17 Isis Pharmaceuticals, Inc. Antisense modulation of CHK2 expression
WO2002059325A2 (fr) * 2000-12-27 2002-08-01 Lexicon Genetics Incorporated Nouvelles kinases humaines et polynucleotides codant ces kinases
EP1224942A1 (fr) * 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Utilisation de JAQ1 (anticorps monoclonal anti-GPVI) en tant que médicament actif pour la protection contre les maladies thrombotiques
AP2048A (en) * 2003-01-09 2009-09-24 Pfizer Diazepinoindole derivatives as kinase inhibitors
WO2005021553A1 (fr) * 2003-08-29 2005-03-10 Pfizer Inc. Carboxamides de naphtalene et leurs derives utiles comme nouveaux agents anti-angiogeniques
CA2536321A1 (fr) * 2003-08-29 2005-03-10 Pfizer Inc. Thienopyridine-phenylacetamides et leurs derives utiles comme nouveaux agents anti-angiogeniques
US8572169B2 (en) * 2006-08-28 2013-10-29 Myspace, Llc System, apparatus and method for discovery of music within a social network
US20100210700A1 (en) 2007-05-08 2010-08-19 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
US8518952B2 (en) * 2008-08-06 2013-08-27 Pfizer Inc. 6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443962A (en) * 1993-06-04 1995-08-22 Mitotix, Inc. Methods of identifying inhibitors of cdc25 phosphatase
US5674748A (en) * 1995-03-14 1997-10-07 Thomas Jefferson University Human cyclin-dependent kinase-like proteins and methods of using the same
PL322876A1 (en) * 1995-11-16 1998-03-02 Icos Corp Pik type kinase of cellular cycle control point: materials and methods
US5744349A (en) * 1996-03-05 1998-04-28 Washington University DNA sequences encoding human Myt1 kinase
US6218109B1 (en) * 1997-09-05 2001-04-17 Baylor College Of Medicine Mammalian checkpoint genes and proteins
GB9722320D0 (en) * 1997-10-22 1997-12-17 Janssen Pharmaceutica Nv Human cell cycle checkpoint proteins

Also Published As

Publication number Publication date
DE69831500D1 (de) 2005-10-13
EP1025236B1 (fr) 2005-07-27
US20050180981A1 (en) 2005-08-18
JP2001520037A (ja) 2001-10-30
AU760544B2 (en) 2003-05-15
JP2001523461A (ja) 2001-11-27
WO1999025843A3 (fr) 1999-08-05
AU1232299A (en) 1999-05-10
CA2306492A1 (fr) 1999-05-27
DE69831500T2 (de) 2006-06-14
ES2245050T3 (es) 2005-12-16
EP1025237A2 (fr) 2000-08-09
US20030017160A1 (en) 2003-01-23
IL135687A (en) 2007-07-04
JP4261050B2 (ja) 2009-04-30
ATE304052T1 (de) 2005-09-15
WO1999020747A2 (fr) 1999-04-29
ATE300619T1 (de) 2005-08-15
IL135688A0 (en) 2001-05-20
US6943013B2 (en) 2005-09-13
CA2306492C (fr) 2014-03-25
NZ503983A (en) 2002-03-28
WO1999025843A2 (fr) 1999-05-27
IL135687A0 (en) 2001-05-20
DE69831007D1 (de) 2005-09-01
GB9722320D0 (en) 1997-12-17
EP1025236A2 (fr) 2000-08-09
IL135688A (en) 2010-04-29
JP4418103B2 (ja) 2010-02-17
DE69831007T2 (de) 2006-04-20
NZ503965A (en) 2002-03-28
ES2245807T3 (es) 2006-01-16
EP1025237B1 (fr) 2005-09-07
AU752617B2 (en) 2002-09-26
WO1999020747A3 (fr) 1999-07-01
AU2612699A (en) 1999-06-07
CA2308013A1 (fr) 1999-04-29
DK1025236T3 (da) 2005-10-24
US6413755B1 (en) 2002-07-02
US7414020B2 (en) 2008-08-19
US6531312B1 (en) 2003-03-11

Similar Documents

Publication Publication Date Title
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
MY120693A (en) Human bikunin
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
BR9814276A (pt) Antìgenos de superfìcie
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
PT81624A (en) Recombinant methods for production of serine protease inhibitors and method for isolation of same
EP1012603A4 (fr) Fragments fonctionnels de la proteine vpr vih-1 et procedes d'utilisation
WO2000061742A3 (fr) Traitement d'une insuffisance cardiaque
WO1998011234A3 (fr) Proteines kinases humaines
DE69934239D1 (de) Ly6h-gen
ATE314474T1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
MX9806041A (es) Proteina purificada sr-p70.
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
EP0723014A3 (fr) ADNc du gène DOCK180 et la protéine DOCK180
WO2002016568A3 (fr) 46863, methyltransferase humaine, et utilisations
WO2000065055A8 (fr) Nouvelles proteines transporteuses humaines
WO2000034294A3 (fr) Homologue recepteur du facteur de necrose tumorale (trh1)
AU2001288284A1 (en) 14189, a human kinase and uses thereof
ECSP972054A (es) Bicunina humana
WO1997039020A3 (fr) Sequences antigeniques d'une proteine seminale et methodes immunocontraceptives